Tiotropium HandiHaler&amp;reg; in the treatment of COPD: A safety review

Kesten, Steven

doi:10.2147/COPD.S4802

ScienceOpen: research and publishing network

For Publishers

For Researchers

Blog
About

Search
Advanced search

views

recommends

International Journal of COPD (submit here)

This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

Record: found
Abstract: found
Article: found

Is Open Access

Tiotropium HandiHaler® in the treatment of COPD: A safety review

Author(s): Steven Kesten

Publication date (Electronic): October 2009

Journal: International Journal of Chronic Obstructive Pulmonary Disease

Publisher: Informa UK Limited

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Author and article information

Journal

Title: International Journal of Chronic Obstructive Pulmonary Disease

Abbreviated Title: COPD

Publisher: Informa UK Limited

ISSN (Electronic): 1178-2005

Publication date (Electronic): October 2009

Page: 397

Article

DOI: 10.2147/COPD.S4802

SO-VID: ee6f1ba1-5462-4411-8b34-0bfc72132ea6

License:

http://creativecommons.org/licenses/by-nc/3.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1

In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
Authors: M. T. Pulido-Rios, A. McNamara, G. P. Obedencio …

See all cited by